To access this element change to forms mode OFF
Grant Award View - GA289051
Developing a promoter-less gene therapy approach for haemophilia A
GA ID:
GA289051
Agency:
Department of Health and Aged Care
Approval Date:
13-Dec-2022
Publish Date:
20-Mar-2023
Category:
Medical Research
Grant Term:
1-Feb-2023 to 31-Jan-2025
Value (AUD):
$513,720.11
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 22/23 1.1 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
Developing a promoter-less gene therapy approach for haemophilia A
Purpose:
Haemophilia A (Factor VIII deficiency) is a bleeding disorder that affects around 3,000 people in Australia. Gene therapy can tackle such deficiencies by delivering the corrective genes to the patient’s cells. However, questions on the durability of such therapies are common. In this proposal, we plan to harness the cellular natural DNA repair process to provide a precise and durable therapy, by safely inserting the correct copy of Factor VIII into a highly expressed region of the human genome.
GO ID:
GO Title:
MRFF - 2021 Early to Mid-Career Researchers Grant Opportunity
Internal Reference ID:
2022/MRF2022949
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Sydney
Recipient ABN:
15 211 513 464
Grant Recipient Location
Suburb:
Camperdown
Town/City:
Camperdown
Postcode:
2050
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, NSW
Postcode:
Multiple
Country:
AUSTRALIA